n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid and Sarcoma--Ewing

n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid has been researched along with Sarcoma--Ewing* in 1 studies

Other Studies

1 other study(ies) available for n-n--bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine-n-n--diacetic-acid and Sarcoma--Ewing

ArticleYear
68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:1

    We present a case of a 19-year-old woman with Ewing sarcoma of the iliac bone in whom Ga-PSMA-HBED-CC PET/CT showed high radiotracer activity in the primary tumor. The present case documents the in vivo expression of PSMA in Ewing sarcoma family of tumors and adds on to the list of nonprostatic malignancies showing PSMA expression.

    Topics: Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing; Young Adult

2020